The science behind the magic

The heart of our mission is to provide quality, side-effect free* care that leaves lasting results.

Our Story

Sapien started out as an NYU Langone project to provide remote tDCS (Transcranial direct current stimulation) care to patients. This novel technique allows us to treat people with mood disorders and motor rehabilitation by neuromodulation and enables neuroplasticity in critical areas.


After pioneering this remote program, we’ve began to expand on treatments where we’ve seen results.

We now offer therapy and guided tDCS sessions to help. Here are some articles on our successes.

We’re working on clinical trials for FDA approval. The highest forms of scrutiny. Until then, we’re cleared to help you directly here.

Research on tDCS and Mood Disorders

  • Frengi et al.

    July 2020

    Key findings: tDCS for depression is extremely effective

    Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders

    Research Publication

  • Nikolen at el.

    March 2023

    Key findings: Treatments peaks after 6 weeks

    Title: Time-course of the tDCS antidepressant effect: An individual participant data meta-analysis

    Link to Research Paper

  • Jog et al.

    Nov 2023

    Key findings: Longterm structural changes are able to be monitored

    Transcranial direct current stimulation (tDCS) in depression induces structural plasticity

    Research Publication

  • Platinum

    What should we know about the services you provide? Better descriptions result in more sales.

    Link to Research Paper